Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Perrone

Showing results (1-10 of 272) with videos related to

Pageof 28
Sort By:
Tumori|October 14, 2006
[ASCO 2006. Exemestane: a new drug for the adjuvant therapy of breast cancer]Francesco Perrone
The Lancet. Oncology|September 2, 2006
Don't forget survival, pleaseFrancesco Perrone
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|June 23, 2004
[Independent clinical research in oncology]Francesco Perrone
The Lancet. Oncology|December 21, 2010
Cetuximab in NSCLC: another trial neededFrancesco Perrone
Recenti Progressi in Medicina|February 24, 2021
From snapshots to a movie. Challenging the patterns of academic researchFrancesco Perrone
Future Oncology (London, England)|January 10, 2015
What is the future for cancer clinical trials?Francesco Perrone
The Lancet. Oncology|May 18, 2013
Surrogate endpoints: can size of effect mitigate perplexity?Francesco Perrone
Ecancermedicalscience|May 29, 2014
International Clinical Trials Day 2014-ancient and modern needsFrancesco Perrone
Recenti Progressi in Medicina|January 27, 2015
[Sustainability and new anticancer drugs]Francesco Perrone
The Lancet. Oncology|December 7, 2019
Denosumab in early breast cancer: negative data and a call to actionFrancesco Perrone, Adriano Gravina
Pageof 28

Showing results (1-10 of 272) with videos related to

Sort By:
Pageof 28
Tumori|October 14, 2006
[ASCO 2006. Exemestane: a new drug for the adjuvant therapy of breast cancer]Francesco Perrone
The Lancet. Oncology|September 2, 2006
Don't forget survival, pleaseFrancesco Perrone
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|June 23, 2004
[Independent clinical research in oncology]Francesco Perrone
The Lancet. Oncology|December 21, 2010
Cetuximab in NSCLC: another trial neededFrancesco Perrone
Recenti Progressi in Medicina|February 24, 2021
From snapshots to a movie. Challenging the patterns of academic researchFrancesco Perrone
Future Oncology (London, England)|January 10, 2015
What is the future for cancer clinical trials?Francesco Perrone
The Lancet. Oncology|May 18, 2013
Surrogate endpoints: can size of effect mitigate perplexity?Francesco Perrone
Ecancermedicalscience|May 29, 2014
International Clinical Trials Day 2014-ancient and modern needsFrancesco Perrone
Recenti Progressi in Medicina|January 27, 2015
[Sustainability and new anticancer drugs]Francesco Perrone
The Lancet. Oncology|December 7, 2019
Denosumab in early breast cancer: negative data and a call to actionFrancesco Perrone, Adriano Gravina
Pageof 28